Results 1 to 10 of about 169,283,811 (262)

The Newcastle–Ottawa Scale for Assessing the Quality of Studies in Systematic Reviews

Publications
Secondary research is a cornerstone of health sciences, with substantial implications for clinical practice and health policy. Within the systematic review process, a key step is assessing study quality and risk of bias.
Emanuela Gualdi-Russo, Luciana Zaccagni
doaj   +1 more source

Identification of concepts of importance for the assessment of internal validity of in vitro toxicology studies using a modified Delphi technique

Evidence-Based Toxicology
Context In vitro toxicity studies are increasingly being included as evidence in systematic reviews and chemical risk assessments. INVITES-IN, a tool for assessing the internal validity of in vitro studies, is under development in a process consisting of
Gro H. Mathisen, Camilla Svendsen, Gunn E. Vist, Trine Husøy, Heather M. Ames, Angela Bearth, Marc Audebert, Annette Bernhard, Anna Beronius, Ellen M. Bruzell, Emma Di Consiglio, Miles Davenport, Ingrid Druwe, René Geci, Ursula Gundert-Remy, Thomas Hartung, Sebastian Hoffmann, Helena T. Hogberg, Carlijn R. Hooijmans, Lucina E. Lizarraga, Jennifer H. Olker, Pilar Prieto, Joshua F. Robinson, Andrew A. Rooney, Adriano Sebollela, Nicola M. Smith, Eliana Spilioti, Anastasia Spyropoulou, Olga Tcheremenskaia, Emanuela Testai, Amy Wang, Erin Yost, Johanna Zilliacus, Paul Whaley   +33 more
doaj   +1 more source

Critical appraisal of systematic reviews and meta-analyses: a step-by-step guide for nephrologists

Renal Failure
Background Systematic reviews and meta-analyses play a pivotal role in evidence-based medicine, including nephrology, by consolidating findings from multiple studies. To maximize their utility, rigorous quality assessment during peer review is essential.
Wisit Cheungpasitporn, Wannasit Wathanavasin, Charat Thongprayoon, Wisit Kaewput, Mihály Tapolyai, Tibor Fülöp   +5 more
doaj   +1 more source

Systematic reviews of clinical laboratory studies: Pilot risk of bias tool developed by consensus

Cochrane Evidence Synthesis and Methods
Introduction Some research studies aim to elucidate pathophysiology by examining blood or tissue markers in relation to clinical findings. In COVID‐19, this has led specialists to promote treatment options based on single studies without systematic ...
Tilly Fox, Beverley J. Hunt, Robert A. S. Ariens, Greg J. Towers, Robert Lever, Paul Garner, Rebecca Kuehn   +6 more
doaj   +1 more source

Prediction models for progression and outcomes in degenerative cervical myelopathy: a systematic review and critical appraisal

Frontiers in Neurology
ObjectiveThis systematic review evaluated the methodological quality, predictive performance, risk of bias, and clinical applicability of prediction models for disease progression and postoperative outcomes in degenerative cervical myelopathy (DCM ...
Renkun Zhao, Bo Xu, Xiaokuan Qin, Peng Zhang, Peng Zhang, Guoliang Ma, Zhizhuang Wang, Dongsheng Yuan, Penghui Li, Jiacheng Zheng, Yaling Gao, He Yin, Bowen Yang, Xin Chen   +13 more
doaj   +1 more source

Explainable artificial intelligence in dental imaging: a systematic review of interpretability and the current state of trust evidence

Frontiers in Dental Medicine
Explainable artificial intelligence (XAI) is increasingly used to improve the transparency of artificial intelligence models in dental and maxillofacial imaging, but the rigor with which explanations are evaluated remains unclear.
Wlla E. Al-Hammad, Mohammad Y. Khatatbeh, Ghaida AlJamal, Mohammed Q. Shatnawi, Bara'a Fawaeer, Salem Alhatamleh, Abdel Rahman F. Shawaqfeh, Haron El-Rasheed Nijim, Muneer A. Al-Refai, Ahmad F. Hindawi, Anas Odat, Shams Eldin M. Saleh, Abdel Rahman M. Alzoubi, Khaled W. Tashtoush, Ahmad M. Alkhamaiseh, Loay E. Al-Hammad   +15 more
doaj   +1 more source

An introduction to Risk of Bias in Network Meta-analysis (RoB NMA) tool [PDF]

Yixue xinzhi zazhi
Existing risk of bias assessment tools are primarily designed for traditional pairwise Meta-analysis and fail to comprehensively evaluate the unique sources of bias risk inherent in network Meta-analysis.
ZHAO Wenshuo, LIU Ming, SHI Jiyuan, LI Lun, YANG Fengwen, XUE Fuzhong, GAO Ya   +6 more
doaj   +1 more source

Bias in published randomized trials that compare collagenase injection with percutaneous needle fasciotomy in the treatment of Dupuytren disease: a systematic review

EFORT Open Reviews
Purpose: Controversy exists regarding the comparative efficacy of collagenase injection and percutaneous needle fasciotomy in the treatment of Dupuytren contracture.
David Eckerdal, Hendrik Pakosta, Muhanned Ali, Isam Atroshi   +3 more
doaj   +1 more source

Risk of Editorial Bias: A Case Study of Factors Contributing to Review Time in a Leading Journal in Dentistry

Clinical and Experimental Dental Research
Objectives The aim of this study was to evaluate the risk of editorial bias in the field of Dentistry by examining surrogate measures which can be readily extracted from published randomized controlled trials (RCTs) in a journal of high impact factor ...
Momen A. Atieh, Nabeel H. M. Alsabeeha
doaj   +1 more source

Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation

Medical Cannabis and Cannabinoids, 2021
Joshua D. Brown, Amie J. Goodin
doaj   +1 more source